Zobrazeno 1 - 10
of 1 051
pro vyhledávání: '"NEW ORAL ANTICOAGULANTS"'
Autor:
Abdirahman Ahmed S, Hassan MO, Abdi IA, Mohamud MA, Waberi MM, Elmi Abdi A, Hassan Fujeyra AM, Ali AA, Sheikh Hassan M
Publikováno v:
International Medical Case Reports Journal, Vol Volume 16, Pp 623-626 (2023)
Said Abdirahman Ahmed,1 Mohamed Omar Hassan,1 Ishak Ahmed Abdi,1 Mohamed Abdullahi Mohamud,1 Mohamud Mire Waberi,1 Ahmed Elmi Abdi,1 Abdullahi Mohamed Hassan Fujeyra,2 Abdijalil Abdullahi Ali,3 Mohamed Sheikh Hassan4 1Department of Cardiology at Moga
Externí odkaz:
https://doaj.org/article/67e943f4d368467a98874f91866861c5
Publikováno v:
Malang Neurology Journal, Vol 9, Iss 2, Pp 134-138 (2023)
Background: Cardioembolic stroke is a category of ischemic stroke that manifests more severe, is prone to recurrence, and is related to a higher mortality rate than the other categories of ischemic stroke. Anticoagulant therapy is recommended in card
Externí odkaz:
https://doaj.org/article/e66a1291962c41beb7384b6be3b6b194
Autor:
Vladimir A. Parfenov
Publikováno v:
Consilium Medicum, Vol 25, Iss 2, Pp 81-85 (2023)
Cognitive disorders (CD) represent one of the leading causes of disability among the elderly. Atrial fibrillation (AF) is an independent and corrected risk factor for CD and dementia. The development of CD with AF is associated with the occurrence of
Externí odkaz:
https://doaj.org/article/b5cfb68d3cf145b78c5e08f5b057025c
Publikováno v:
Journal of Medical Case Reports, Vol 17, Iss 1, Pp 1-5 (2023)
Abstract Background Coronavirus disease 2019 was spread worldwide, as a pandemic, from December 2019. Venous thromboembolism events can inflict patients with coronavirus disease 2019 during the hospitalization or convalescent period. Therefore, monit
Externí odkaz:
https://doaj.org/article/f4200fa124844a06b255555321fd90e5
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 3, Pp 293-301 (2022)
Therapeutically, new oral anticoagulants (NOACs) are considered to be non-inferior or superior to vitamin K antagonists (warfarin). NOACs are included in current guidelines for the treatment of various cardiovascular diseases. Rivaroxaban medicinal p
Externí odkaz:
https://doaj.org/article/1ecd4bfd45f44ba9bc9d615dd74eba97
Autor:
O. Chernatska
Publikováno v:
Український Журнал Нефрології та Діалізу, Iss 4(80) (2023)
This study aimed to investigate the prescribing patterns of new oral anticoagulants in atrial fibrillation patients based on creatinine clearance. A thorough analysis of articles published between 2017 and 2021 in databases such as PubMed, Scopus, an
Externí odkaz:
https://doaj.org/article/ef5aa0422f884d119ce2ea16487f3848
Autor:
Lu Wang, Wanyue Sang, Yi Jian, Xiaoxue Zhang, Yafan Han, Feifei Wang, Liang Wang, Suxia Yang, Subinuer Wubulikasimu, Li Yang, Huaxin Sun, Yaodong Li
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
ObjectiveThis study aimed to compare the efficacy of novel oral anticoagulants (NOACs) with traditional anticoagulants vitamin K antagonists (VKAs) in patients with atrial fibrillation (AF) post transcatheter aortic valve replacement (TAVR).MethodsSt
Externí odkaz:
https://doaj.org/article/ea0480e200684d2d91ca14c1cce27e71
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 16, Pp 2497-2507 (2022)
Kaidireyahan Wumaier,1 Wenqian Li,1 Jiuwei Cui2 1The First Hospital of Jilin University, Jilin University, Changchun, People’s Republic of China; 2Department of Cancer Center, the First Hospital of Jilin University, Changchun, People’s Republic o
Externí odkaz:
https://doaj.org/article/3e270d55cf504767a158d0b7359a2665
Autor:
Roxana Radu, Octavian Dincă, Cristina Pădurariu, Tiberiu Niță, Cristian Vlădan, Alexandru Bucur
Publikováno v:
Romanian Journal of Oral Rehabilitation, Vol 14, Iss 1, Pp 74-77 (2022)
Aim of the study Oral anticoagulants are effective therapies for reduction of stroke risk in patients with atrial fibrillation. However, blocking elements of the clotting cascade carries an inherent risk of bleeding. Also, anticoagulated patients som
Externí odkaz:
https://doaj.org/article/b5b7f531554a47bab26d5e520d0e3286
Autor:
Roxana Radu, Octavian Dincă, Cristina Pădurariu, Tiberiu Niță, Cristian Vlădan, Alexandru Bucur
Publikováno v:
Romanian Journal of Oral Rehabilitation, Vol 14, Iss 1, Pp 97-101 (2022)
Aim of the study Oral anticoagulants have been used to prevent first or recurrent stroke, especially among patients with arterial fibrillation and y atherosclerotic disease. Despite the widespread use in dental patients, safety of anticoagulants a
Externí odkaz:
https://doaj.org/article/26484f8c98df42299b921e52c899944e